Picture of Abivax SA logo

ABVX — Abivax SA News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapSucker Stock

Abivax SA expected to post a loss of 74 cents a share - Earnings Preview

* Abivax SA  ABVX.OQ   ABVX.O  is expected to report
resultson
September 9 for the period ending March 31 2024
    * The Paris Ile-de-france-based  company is expected to
report
revenue of €1.123 million, according to the estimate from one
analyst, based on LSEG data.
    * ​LSEG's mean analyst estimate for Abivax SA is for a loss
of 74
cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Abivax SA
is
42.00​, above​ its last closing price of $12.28. ​​​

This summary was machine generated September 6 at 16:02 GMT. 
All figures in euros unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Abivax SA

See all news